Produktname:8-{[3-(4-phenyl-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl]sulfonyl}quinoline

IUPAC Name:8-{[3-(4-phenyl-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl]sulfonyl}quinoline

CAS:2034445-79-7
Molekulare Formel:C21H19N5O2S
Reinheit:95%+
Katalognummer:CM911645
Molekulargewicht:405.48

Packungseinheit Verfügbarer Vorrat Preis($) Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:2034445-79-7
Molekulare Formel:C21H19N5O2S
Schmelzpunkt:-
SMILES-Code:O=S(=O)(N1CCC(C1)N1C=C(N=N1)C1=CC=CC=C1)C1=CC=CC2=CC=CN=C12
Dichte:
Katalognummer:CM911645
Molekulargewicht:405.48
Siedepunkt:
Mdl-Nr.:
Lagerung:

Category Infos

Quinolines
Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.
Quinoline Price
if you have any question on quinoline price, we will give the professional answers to your short questions.
Pyrrolidines
Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.